| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 3405528 | Journal des Anti-infectieux | 2012 | 7 Pages |
Abstract
Prospective clinical trials focusing on homogenous patient groups are urgently needed to better define when ESC and AZT could be used for treating successfully infections due to ESBL-producing Enterobacteriaceae.
Keywords
Related Topics
Health Sciences
Medicine and Dentistry
Infectious Diseases
Authors
A. Lefort, M.-H. Nicolas-Chanoine,